CD8A and neoplasm: Hence, TCF-1+CD8+ TPEX cells migrating from lymph nodes to tumor sites provide a therapeutic window for maintaining a proliferative T cell population and possibly preventing differentiation of a terminal exhausted state of T cells (48, 55).